| #474 |
Maurice Galli |
Harry Winston Sa |
2 |
| #474 |
Carl Asman |
— |
2 |
| #474 |
Tye L. Rattenbury |
Nike |
2 |
| #474 |
Paul K. Isbester |
Takeda Pharmaceutical Company Limited |
2 |
| #474 |
Brent R. Stockwell |
Columbia University |
2 |
| #474 |
Shaun B. Stewart |
Delos Living |
2 |
| #474 |
John J. Viscogliosi |
Centinel Spine |
2 |
| #474 |
Samie R. Jaffrey |
Cornell University |
2 |
| #474 |
David E. Nachman |
IBM |
2 |
| #474 |
Pierre Radyn Swart |
Chrome Cherry Limited |
2 |
| #474 |
Travis H. K. Green |
Google |
2 |
| #474 |
Jeffrey D. Lee |
Regeneron Pharmaceuticals |
2 |
| #474 |
Benjamin S. Akkad |
Idea Nuova |
2 |
| #474 |
Alexander D. Deitz |
Trading Technologies International |
2 |
| #474 |
Rock Positano |
Roxilla |
2 |
| #474 |
Robert J. DeVita |
Merck |
2 |
| #474 |
Jessica Corr |
— |
2 |
| #474 |
David Verbel |
Endo Pharmaceuticals |
2 |
| #474 |
Patrick Sean Harper |
Kaddan Entertainment |
2 |
| #474 |
Frederick H. Balboni |
IBM |
2 |
| #474 |
William Beckler |
Alltherooms |
2 |
| #474 |
Niels Diffrient |
Humanscale |
2 |
| #474 |
Duncan Jackson |
Grimshaw Industrial Design |
2 |
| #474 |
William Meyer |
Rbw Studio |
2 |
| #474 |
Yaroslav Faybishenko |
Oracle |
2 |
| #474 |
Raanan Shamir |
Technion Research & Development Foundation Limited |
2 |
| #474 |
Nemanja Vukanovic |
— |
2 |
| #474 |
Swati Mittal |
Fujitsu Limited |
2 |
| #474 |
Erick Berglund |
Allovate |
2 |
| #474 |
Nick Matviko |
Securityscorecard |
2 |
| #474 |
Michelle A. Badalich |
Gabrielle Studio |
2 |
| #474 |
Alexandra Szakats |
— |
2 |
| #474 |
Antony Brydon |
Directly Software |
2 |
| #474 |
Lindsey Adelman |
Lindsey Adelman Studio |
2 |
| #474 |
Katherine Powers |
The Radio Flyer |
2 |
| #474 |
Benjamin Aisen |
Iex Group |
2 |
| #474 |
Tara McKee |
Iex Group |
2 |
| #474 |
Peter M Roncetti |
— |
2 |
| #474 |
Casimir Algis Zdanius |
Tecno S.P.A. |
2 |
| #474 |
Partha P. Mitra |
Clarapath |
2 |
| #474 |
Andrew M. Zuckerman |
Different Dimensions |
2 |
| #474 |
Christopher U. Missling |
Anavex Life Sciences |
2 |
| #474 |
Allen Radin |
Regeneron Pharmaceuticals |
2 |
| #474 |
David Tashjian |
Linq3 Technologies |
2 |
| #474 |
Daniel Cage |
Linq3 Technologies |
2 |
| #474 |
Jacob Rosenstein |
Columbia University |
2 |
| #474 |
Matthew Anderson |
State Farm |
2 |
| #474 |
Bernhard Valenti |
Ack Ventures Holdings |
2 |
| #474 |
Winston Felix Popowicz Handte |
Meta |
2 |
| #474 |
Roger N. Anderson |
Applied Materials |
2 |